Biliary Atresia Clinical Trials

17 recruitingLast updated: May 21, 2026

There are 17 actively recruiting biliary atresia clinical trials across 9 countries. Studies span Not Applicable, Phase 1, Early Phase 1, Phase 2. Top locations include Shanghai, Shanghai Municipality, China, Pittsburgh, Pennsylvania, United States, Chicago, Illinois, United States. Updated daily from ClinicalTrials.gov.


Biliary Atresia Trials at a Glance

17 actively recruiting trials for biliary atresia are listed on ClinicalTrialsFinder across 6 cities in 9 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Shanghai, Pittsburgh, and Chicago. Lead sponsors running biliary atresia studies include Children's Hospital of Fudan University, Arbor Research Collaborative for Health, and Boston Children's Hospital.

Browse biliary atresia trials by phase

About Biliary Atresia Clinical Trials

Looking for clinical trials for Biliary Atresia? There are currently 17 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Biliary Atresia trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Biliary Atresia clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 117 of 17 trials

Recruiting
Not Applicable

Preventive Effect of Prophylactic Oral Antibiotics Against Cholangitis After Kasai Portoenterostomy

Biliary AtresiaCholangitisAnti-Bacterial Agents
Children's Hospital of Fudan University356 enrolled1 locationNCT05925309
Recruiting
Phase 1Phase 2

Use of Indocyanine Green (ICG) for the Diagnosis of Biliary Atresia

Biliary Atresia
Boston Children's Hospital20 enrolled1 locationNCT07513038
Recruiting

High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia

Nutrition supportBiliary AtresiaInfant+1 more
Children's Hospital of Fudan University300 enrolled1 locationNCT05072626
Recruiting

Preoperative Serum FGF19 in the Prognosis of Biliary Atresia

PrognosisBiliary Atresia
Children's Hospital of Fudan University200 enrolled1 locationNCT05848310
Recruiting
Early Phase 1

The Use of Near-Infrared Fluorescence Cholangiography With Indocyanine Green (ICG) in the Work Up of Neonatal Cholestasis

Biliary AtresiaKasaiCholestasis in Newborn+1 more
University of Alabama at Birmingham15 enrolled1 locationNCT07250854
Recruiting
Not Applicable

Nutritional Intervention for Biliary Atresia

Biliary AtresiaNutrition Disorder, Infant
Tongji Hospital120 enrolled1 locationNCT06764082
Recruiting

Biliary Atresia Study in Infants and Children

Biliary Atresia
Arbor Research Collaborative for Health1,265 enrolled16 locationsNCT00345553
Recruiting

A Prospective Database of Infants With Cholestasis

Biliary Atresia
Arbor Research Collaborative for Health1,000 enrolled16 locationsNCT00061828
Recruiting

Mapping Disease Pathways for Biliary Atresia

Biliary Atresia
University of Pittsburgh1,100 enrolled1 locationNCT03273049
Recruiting

Biliary Atresia Research Network Northeast

Biliary Atresia
Yale University150 enrolled14 locationsNCT06184971
Recruiting

Rare Disease Patient Registry & Natural History Study - Coordination of Rare Diseases at Sanford

Multiple Endocrine Neoplasia Type 1Multiple Endocrine Neoplasia Type 2Rare Disorders+337 more
Sanford Health20,000 enrolled2 locationsNCT01793168
Recruiting
Not Applicable

Evaluation of the Use of Granulocyte Colony Stimulating Factor (GCSF) in Post Kasai Type 3 Biliary Atresia

Biliary AtresiaGranulocyte Colony-stimulating Factor
National Liver Institute, Egypt40 enrolled1 locationNCT06708572
Recruiting
Not Applicable

Stem Cell Applications in Biliary Atresia Patients

Fibrosis, LiverBiliary AtresiaStem Cell
Necmi Kadıoğlu Hospital64 enrolled1 locationNCT06564740
Recruiting

BILACO Trial: Biliary Atresia - a Severe Complex Congenital Liver Disease

Cognitive ImpairmentBiliary Atresia
Rigshospitalet, Denmark100 enrolled1 locationNCT05399745
Recruiting
Not Applicable

Molecular Characterization for Understanding Biliary Atresia

Biliary Atresia
Institut National de la Santé Et de la Recherche Médicale, France100 enrolled2 locationsNCT04272515
Recruiting
Phase 1

Treating Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin

Primary Sclerosing CholangitisBiliary Atresia
Sacramento Pediatric Gastroenterology200 enrolled1 locationNCT02137668
Recruiting

Using a Stool Colour Chart in the care of the new-born - A qualitative study

Biliary AtresiaNeonatal cholestasis
Stanley Ng15 enrolled1 locationACTRN12615000274572